Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARi: Immediate Versus Early ART Initiation in Hospitalized HIV/AIDS Patients
NCT03825523Completed
- Start
- Jan 2018
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in human immunodeficiency virus infection (HIV) (2 arms). Primary endpoint: All-cause mortality at 30 days. Started Jan 2018; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03825523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825523.